ARTICLE | Company News
MannKind, Sanofi deal
January 11, 2016 8:00 AM UTC
Sanofi terminated an August 2014 deal with MannKind granting the pharma exclusive, worldwide rights to develop and commercialize Afrezza to treat adults with Type I or II diabetes. Sanofi said the de...